|
N- [(2S,3R,4R,5S,6R)- 2- [(2R,3S,4S,5R,6S)- 3,5- Dihydroxy- 2- (hydroxymethyl)- 6- [(2R,3S,4R,5R)- 4,5,6- trihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxyoxan- 4- yl]oxy- 6- (hydroxymethyl)- 4,5- bis[[(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxy]oxan- 3- yl]acetamide |
|
CHEBI:149022 |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by a third party.
|
|
Gareth Owen
|
|
No supplier information found for this compound. |
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C32H55NO26/c1- 7(39) 33- 13- 26(58- 31- 22(48) 18(44) 15(41) 9(3- 35) 53- 31) 25(57- 30- 21(47) 17(43) 14(40) 8(2- 34) 52- 30) 12(6- 38) 55- 29(13) 59- 27- 16(42) 10(4- 36) 54- 32(23(27) 49) 56- 24- 11(5- 37) 51- 28(50) 20(46) 19(24) 45/h8- 32,34- 38,40- 50H,2- 6H2,1H3,(H,33,39) /t8- ,9- ,10- ,11- ,12- ,13- ,14+,15+,16+,17+,18+,19- ,20- ,21- ,22- ,23- ,24- ,25- ,26- ,27+,28?,29+,30+,31+,32+/m1/s1 |
NIBCVDURCUAARI-BJVZEYSVSA-N |
O1[C@@H] (O[C@@H] 2[C@@H] (O) [C@@H] (O[C@@H] ([C@@H] 2O) CO) O[C@H] 3[C@H] (O) [C@@H] (O) C(O[C@@H] 3CO) O) [C@H] (NC(=O) C) [C@@H] (O[C@@H] 4O[C@@H] ([C@H] (O) [C@H] (O) [C@H] 4O) CO) [C@H] (O[C@@H] 5O[C@@H] ([C@H] (O) [C@H] (O) [C@H] 5O) CO) [C@H] 1CO |
|
Outgoing
|
N- [(2S,3R,4R,5S,6R)- 2- [(2R,3S,4S,5R,6S)- 3,5- Dihydroxy- 2- (hydroxymethyl)- 6- [(2R,3S,4R,5R)- 4,5,6- trihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxyoxan- 4- yl]oxy- 6- (hydroxymethyl)- 4,5- bis[[(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxy]oxan- 3- yl]acetamide
(CHEBI:149022)
is a
oligosaccharide
(CHEBI:50699)
|
|
beta- D- galacto- hexopyranosyl- (1- >3)- [beta- D- galacto- hexopyranosyl- (1- >4)]- 2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1- >3)- beta- D- galacto- hexopyranosyl- (1- >4)- D- gluco- hexopyranose
|
SUBMITTER
|
Gal(b1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)Glc
|
SUBMITTER
|
WURCS=2.0/3,5,4/[a2122h- 1x_1- 5][a2112h- 1b_1- 5][a2122h- 1b_1- 5_2*NCC/3=O]/1- 2- 3- 2- 2/a4- b1_b3- c1_c3- d1_c4- e1
|
SUBMITTER
|
|